Výsledky vyhledávání - "Carlos M.M. Araújo"

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis

Autor: Héliton Spíndola Antunes, Daniel Herchenhorn, Gabriela de Assis Ramos, Fernando Luiz Dias, Celia Maria Pais Viégas, Isabele Avila Small, Carlos Gil Ferreira, Carlos M.M. Araújo

Publikováno v: Oral Oncology. 71:11-15

Background The impact of low-level laser therapy (LLLT) to prevent oral mucositis in patients treated with exclusive chemoradiation therapy remains unknown. This study evaluated the overall, disease-free and progression-free survival of these patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::569499e42a8177e1e92d888c554bb5c4
https://doi.org/10.1016/j.oraloncology.2017.05.018

Zobrazit plný text záznamu

Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation

Autor: Celia Maria Pais Viégas, Nelson Teich, Carlos M.M. Araújo, Héliton Spíndola Antunes, Fernando Luiz Dias, Daniel Herchenhorn, Elza Maria de Sá Ferreira, Isabele Avila Small, Mariana P. Rampini, Carlos Gil Ferreira, Vanessa Teich, Luciene Schluckebier

Publikováno v: Oral Oncology. 52:85-90

Summary Background Oral mucositis is a major event increasing treatment costs of head and neck squamous cell carcinoma (HNSCC) patients treated with chemoradiation (CRT). This study was designed to estimate the cost-effectiveness of low-level laser t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc43e09ab888c50003a7605d12603656
https://doi.org/10.1016/j.oraloncology.2015.10.022

Zobrazit plný text záznamu

Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma

Autor: Felipe Erlich, Alessandra Marins, Marcos A. Bezerra, Edward C. Lusis, Lilian Dantonino Faroni, Ana Paula Victorino, Carlos Gil Ferreira, Leonaldson Castro, Bruno Pereira, Fernando M. Vieira, Carlos M.M. Araújo, Luis O. Olivatto

Publikováno v: Cancer. 119:2973-2980

BACKGROUND This study sought to determine the feasibility and recommended phase 2 dose (RP2D) of the combination of cetuximab with chemoradiotherapy based on 5-fluorouracil (5-FU) and cisplatin (CP) in locally advanced anal canal carcinoma. METHODS C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ab85b52959a79fabbfa12f8baf5ba668
https://doi.org/10.1002/cncr.28045

Zobrazit plný text záznamu

Phase I/II Study of Erlotinib Combined With Cisplatin and Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Autor: Miriam Hatsue Honda Federico, Renato G. Martins, Renata E. Knust, Celia Maria Pais Viégas, Carlos Gil Ferreira, Daniel Herchenhorn, Fernando Luiz Dias, Marcos A. Bezerra, I. A. Small, Carlos M.M. Araújo, K. Fontão

Publikováno v: International Journal of Radiation Oncology*Biology*Physics. 78:696-702

Purpose Erlotinib, an oral tyrosine kinase inhibitor, is active against head-and-neck squamous cell carcinoma (HNSCC) and possibly has a synergistic interaction with chemotherapy and radiotherapy. We investigated the safety and efficacy of erlotinib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c280352edfaa8541e54df095c62f284d
https://doi.org/10.1016/j.ijrobp.2009.08.079

Zobrazit plný text záznamu

Timing of radiation in children with medulloblastoma/PNET

Autor: Carlos M.M. Araújo, Marcos A. Santos, Renata A. Servidoni, Maria Isabel Pinel, Mário Henrique M. Barros, Celia Maria Pais Viégas

Publikováno v: Pediatric Blood & Cancer. 48:416-422

Background To evaluate the importance of timing of radiation therapy in children with PNET/medulloblastoma, treated at the Brazilian National Cancer Institute (INCA). Procedure The records of 101 children with confirmed diagnosis of medulloblastoma w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce25aa50a83435c6e040312913b840b
https://doi.org/10.1002/pbc.21049

Zobrazit plný text záznamu

Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy

Autor: Carlos M.M. Araújo, Bettina Wolff, Arthur Accioly Rosa, Celia Maria Pais Viégas, Rachele Grazziotin Reisner, Igor Moreira Veras, Maria Aparecida Ferreira, Túlio Meneses Carneiro, Edson Marchiori, Márcio Lemberg Reisner

Publikováno v: Brachytherapy. 14(1)

Background and Purpose Esophageal neoplasm has a poor prognosis, and palliative care remains an important goal of treatment. The purpose of this study was to assess the ability of high-dose-rate brachytherapy (HDRB) to improve dysphagia in 115 patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71ca25fbb75daecd86bc05ca40e7f951
https://pubmed.ncbi.nlm.nih.gov/25447340

Zobrazit plný text záznamu

Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation

Autor: Fernando Luiz Dias, Carlos M.M. Araújo, Celia Maria Pais Viégas, Mariana P. Rampini, Tereza Giannini Pereira da Silva, Pedro Carvalho Rodrigues, Isabele Avila Small, Carlos Gil Ferreira, Daniel Herchenhorn, Elida Cabral, Héliton Spíndola Antunes, Elza Maria de Sá Ferreira

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 109(2)

Background Oral mucositis (OM) is a complication of chemoradiotherapy treatment of head and neck squamous cell carcinoma (HNSCC) patients with no effective therapy. This study was designed to assess the efficacy of preventive low-level laser therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584c8ce1d447adeed61545f8d718721d
https://pubmed.ncbi.nlm.nih.gov/24044799

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání